Explore new innovations for cell culture with a focus on protein expression, cell line development, process optimisation, PAT and outsourcing manufacture
Gain insight into how to optimise your cell culture output and speed through new research and case studies of how others are doing so
Understand how technological advances in areas such as gene expression, 3D applications and disposables are driving cell culture forward
Identify new business and partnership opportunities to develop and speed up cell culture and bioprocess
Learn from cutting edge researchers about the importance of information sharing and collaboration with the industry
Promote your products and services to high-level representatives of leading pharma and biotech companies.
‘It was a very specialized exhibition and it was very well sorted and arranged. Every topic in Cell Culture was covered and the knowledge base was huge. The catering service was also fantastic’
Product Specialist, Abbott GmbH
Dr Manuel Carrondo, Director, Instituto de Biologia Experimental e Tecnologica
Mr Berthold Boedeker, Chief Scientist and Head of Cell Culture, Bayer Pharma Germany Ag
Dr Hansjörg Hauser, Group Leader of R.D.I.F., Helmholtz Centre for Infection Research GmbH
Mr Thomas Fletcher, Scientific Director, Irvine Scientific
'Very well organised conference with excellent networking facilities'
Nico Verlinden, Perkin Elmer
‘Good exhibition area, good traffic’
Rudolf Schmitt, GE Healthcare Europe
‘Interesting talks and high level discussions with good networking’
Markus Sack, RWTH Aachen University
At the World Drug Safety Congress Europe 2014 event, Lesly Wise, Takeda development Centre Europe, gave the presentation “Changing faceof Benefit Risk Management.” Download and ...
At last year’s Pharma Compliance Europe event, Peter Elam, Head of Internal Audit, Novartis, gave the presentation “Collaboration between Internal Audit and Compliance.” Download and ...
The post Collaboration between Internal Audit and Compliance appeared first on Total Biopharma.
Earlier this year, a promising antibiotic named teixobactin with the ability to vanquish drug-resistant pathogen was discovered. Early results show teixobactin to be active against the deadly bacterium ...
The post Uncharted territory: iCHIP’s potential to generate high-throughput antibiotic production appeared first on Total Biopharma.
Innovation and strategy for pharmaceutical, biotech and R&D